The U.S. inked a deal to provide 380 million Covid-19 tests manufactured by
The announcement Thursday marks the next step in Biden’s plan to counter surging cases of the omicron variant of the coronavirus. At the same time, the U.S. is facing a shortage of tests and long lines persist at testing centers across the country. Retailers are having trouble keeping at-home kits in stock and are raising prices.
It’s not ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.